Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 604

1.

CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.

Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, Wegenka UM, Nakayama T, Niess JH.

J Immunol. 2012 Feb 15;188(4):2001-13. doi: 10.4049/jimmunol.1100765. Epub 2012 Jan 16.

2.

The early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestine.

Radulovic K, Rossini V, Manta C, Holzmann K, Kestler HA, Niess JH.

PLoS One. 2013 Jun 12;8(6):e65413. doi: 10.1371/journal.pone.0065413. Print 2013.

3.

MHC-II-independent CD4+ T cells induce colitis in immunodeficient RAG-/- hosts.

Trobonjaca Z, Leithäuser F, Möller P, Bluethmann H, Koezuka Y, MacDonald HR, Reimann J.

J Immunol. 2001 Mar 15;166(6):3804-12.

4.

Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.

Totsuka T, Kanai T, Nemoto Y, Tomita T, Tsuchiya K, Sakamoto N, Okamoto R, Watanabe M.

Eur J Immunol. 2008 May;38(5):1275-86. doi: 10.1002/eji.200737914.

5.
6.

IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.

Tomita T, Kanai T, Totsuka T, Nemoto Y, Okamoto R, Tsuchiya K, Sakamoto N, Ohteki T, Hibi T, Watanabe M.

Eur J Immunol. 2009 Oct;39(10):2737-47. doi: 10.1002/eji.200838905.

7.
8.

CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.

Martín P, Gómez M, Lamana A, Cruz-Adalia A, Ramírez-Huesca M, Ursa MA, Yáñez-Mo M, Sánchez-Madrid F.

Mol Cell Biol. 2010 Oct;30(20):4877-89. doi: 10.1128/MCB.00456-10. Epub 2010 Aug 9.

10.

Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.

Claesson MH, Bregenholt S, Bonhagen K, Thoma S, Möller P, Grusby MJ, Leithäuser F, Nissen MH, Reimann J.

J Immunol. 1999 Mar 15;162(6):3702-10.

11.

B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.

Liu Z, Geboes K, Hellings P, Maerten P, Heremans H, Vandenberghe P, Boon L, van Kooten P, Rutgeerts P, Ceuppens JL.

J Immunol. 2001 Aug 1;167(3):1830-8.

12.

CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.

Yurchenko E, Levings MK, Piccirillo CA.

Eur J Immunol. 2011 Dec;41(12):3455-66. doi: 10.1002/eji.201141814. Epub 2011 Nov 10.

13.

In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.

Tsang J, Jiang S, Tanriver Y, Leung E, Lombardi G, Lechler RI.

Int Immunopharmacol. 2006 Dec 20;6(13-14):1883-8. Epub 2006 Sep 1.

PMID:
17161341
14.

Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.

Krajina T, Leithäuser F, Möller P, Trobonjaca Z, Reimann J.

Eur J Immunol. 2003 Apr;33(4):1073-83.

15.

Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.

Nemoto Y, Kanai T, Makita S, Okamoto R, Totsuka T, Takeda K, Watanabe M.

Gastroenterology. 2007 Jan;132(1):176-89. Epub 2006 Oct 25. Erratum in: Gastroenterology. 2007 May;132(5):2082.

PMID:
17241870
16.
17.

Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.

Huibregtse IL, Snoeck V, de Creus A, Braat H, De Jong EC, Van Deventer SJ, Rottiers P.

Gastroenterology. 2007 Aug;133(2):517-28. Epub 2007 May 3.

PMID:
17681173
18.
19.

Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis.

Strauch UG, Obermeier F, Grunwald N, Gürster S, Dunger N, Schultz M, Griese DP, Mähler M, Schölmerich J, Rath HC.

Gut. 2005 Nov;54(11):1546-52. Epub 2005 Jun 29.

20.

Supplemental Content

Support Center